# Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder

> **NCT04197102** · PHASE2 · SUSPENDED · sponsor: **University of Texas at Austin** · enrollment: 150 (estimated)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** CBD Isolate
- **OTHER:** CBD Broad Spectrum
- **OTHER:** Placebo oil

## Key facts

- **NCT ID:** NCT04197102
- **Lead sponsor:** University of Texas at Austin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-01-15
- **Primary completion:** 2024-05
- **Final completion:** 2025-05
- **Target enrollment:** 150 (ESTIMATED)
- **Why stopped:** Suspended (The UT IRB determined that CBD oil is being used as a drug as defined by the FDA. Therefore, an IND must be obtained for the use of CBD oil in this research study in accordance with FDA regulations, 21 CFR 312.)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04197102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04197102, "Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04197102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*